TB500
TB-500 is a synthetic peptide derived from thymosin beta-4 that has attracted significant research interest for its potential role in tissue repair, cell migration, angiogenesis, and regenerative biology. Supplied as a high-purity lyophilised peptide for laboratory research purposes only.
$97.00 – $147.00Price range: $97.00 through $147.00
Add to wishlist Add to compareAsk about productDescription
TB-500 is a synthetic peptide based on the active region of thymosin beta-4, a naturally occurring protein found throughout the body that plays an important role in cell migration, tissue repair, and regeneration. It has become a widely studied peptide in regenerative medicine due to its involvement in wound healing, angiogenesis, and the organisation of the actin cytoskeleton.
Researchers have investigated TB-500 in a variety of preclinical models examining connective tissue repair, muscle recovery, inflammation, and vascular development. Its ability to influence cellular movement and tissue remodelling continues to make it a valuable research tool for studying regenerative biological processes.
Areas of Scientific Interest
- Research has investigated TB-500 for its potential role in supporting cell migration and tissue remodelling during the repair process.
- Experimental studies have explored its influence on angiogenesis (the formation of new blood vessels) and wound healing in preclinical models.
- Researchers have examined TB-500 in studies involving tendon, ligament, muscle, and connective tissue physiology.
- Ongoing investigations continue to evaluate the role of thymosin beta-4-derived peptides in regenerative biology, inflammation, and cellular repair mechanisms.
Product Features
- High-purity lyophilised peptide
- Contains 10mg TB-500
- Manufactured for laboratory and scientific research
- Quality tested for identity and purity
- Securely packaged to help maintain product integrity
References
- Goldstein AL, Kleinman HK. Advances in the basic and clinical applications of thymosin β4. Expert Opinion on Biological Therapy. 2010.
- Malinda KM, et al. Thymosin beta-4 accelerates wound healing through promotion of cell migration and angiogenesis. FASEB Journal. 1999.
- Smart N, Risebro CA, Melville AAD, et al. Thymosin β4 induces adult epicardial progenitor mobilisation and improves cardiac repair in experimental models. Nature. 2007.
Additional information
| Mg | 5mg, 10mg |
|---|




Reviews
There are no reviews yet.